AstraZeneca
AZN
AZN
766 hedge funds and large institutions have $26B invested in AstraZeneca in 2021 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 265 increasing their positions, 235 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
766
Holders Change
+15
Holders Change %
+2%
% of All Funds
13.37%
Holding in Top 10
11
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-21.43%
% of All Funds
0.19%
New
86
Increased
265
Reduced
235
Closed
62
Calls
$681M
Puts
$477M
Net Calls
+$204M
Net Calls Change
+$65.9M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$593M |
| 2 |
Citigroup
New York
|
+$373M |
| 3 |
Goldman Sachs
New York
|
+$309M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$236M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$233M |
Top Sellers
| 1 |
BlackRock
New York
|
-$338M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$215M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$182M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$173M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$105M |
